[5] The primary objective of the current study is to investigate the association between drospirenone and the diagnosis of hyperkalemia in a large unselected population. A secondary objective is ...

In a study of women taking drospirenone together with an ACE inhibitor, no significant differences were observed in the potassium levels when compared to the placebo. You may need to use ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

*Close price adjusted for splits.**Adjusted close price adjusted for splits and dividend and/or capital gain distributions. Loading more data ...

In a large cohort of young women, drospirenone did not cause a clinically significant increase in risk for hyperkalemia when compared with other progestin-containing OCs. It is however concerning ...